logo

For the Inventor, By the Inventor

Victoria, Australia

Brad E Sleebs

This inventor holds 15 USPTO granted patents and 5 published patent applications. Top assignees: Bionomics Inc., Genentech, Inc., Walter and Eliza Hall Institute of Medical Research. Active years: 2012-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brad E Sleebs. Retrieved from https://idiyas.com/inventor/brad-e-sleebs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 

% Patents Active = 93.3

Average Co-Inventor Count = 7.4

ph-index = 7

Forward Citations = 170(Granted Patents)


Location History:

  • Bundoora, AU (2015)
  • Reservoir, AU (2012 - 2021)
  • Victoria, AU (2023)

Company Filing History:

goldMedal9 out of 64 
 
Bionomics Inc.
 patents
silverMedal5 out of 3,300 
 
Genentech, Inc.
 patents
bronzeMedal5 out of 84 
 
Walter and Eliza Hall Institute of Medical Research
 patents
4. 2 out of 4,189 
 
Abbott Laboratories Corporation
 patents
5. 2 out of 827 
 
Abbvie Inc.
 patents
6. 1 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
where one patent can have more than one assignee

Years Active: 2012-2023

Loading Chart...
15 patents (USPTO):Explore Patents
1. 11766435 - N3-substituted iminopyrimidinones as antimalarial agents (2023-09-26),
2. 10954231 - Anxiolytic compounds (2021-03-23),
3. 10233181 - Anxiolytic compounds (2019-03-19),
4. 9975892 - Anxiolytic compounds (2018-05-22),
5. 9573945 - Anxiolytic compounds (2017-02-21),
6. 9067928 - Compounds and methods of use (2015-06-30),
7. 9023848 - Small-molecules as therapeutics (2015-05-05),
8. 8906912 - Anxiolytic compounds (2014-12-09),
9. 8614212 - Anxiolytic compounds (2013-12-24),
10. 8551990 - Anxiolytic compounds (2013-10-08),
11. 8518970 - Compounds and methods of use (2013-08-27),
12. 8293737 - Anxiolytic compounds (2012-10-23),
13. 8232273 - Heterocyclic compounds and methods of use (2012-07-31),
14. 8168645 - Arylsulfonamide compounds (2012-05-01),
15. 8114893 - Compounds and methods of use (2012-02-14),

Title: Brad E Sleebs: Pioneering Innovations for a Better World

Introduction:

Brad E Sleebs, a visionary inventor based in Victoria, Australia, continues to captivate the world with his innovative spirit and unwavering dedication to creating a positive impact through his pioneering inventions.

Latest Patents:

1. N3-substituted iminopyrimidinones as antimalarial agents: Brad's groundbreaking invention focuses on methods of treating malaria by administering specific compounds. This invention highlights his commitment to advancing healthcare solutions and combating life-threatening diseases.

2. Anxiolytic compounds: Brad's invention of chemical compounds with therapeutic potential in treating anxiety disorders underscores his versatility in addressing a broad spectrum of central nervous system disorders.

Career Highlights:

With an impressive portfolio of 15 patents, Brad E Sleebs has established himself as a leading figure in the field of innovation. His relentless pursuit of excellence has led to significant contributions in diverse areas of science and medicine.

Collaborations:

Throughout his career, Brad has collaborated with esteemed professionals such as Jonathan Bayldon Baell and Chinh Thien Bui, enhancing his ability to bring cutting-edge solutions to the forefront of research and development.

Conclusion:

In conclusion, Brad E Sleebs' trailblazing work serves as a beacon of inspiration for aspiring inventors worldwide. His innovative endeavors not only demonstrate the transformative power of creativity but also underscore the profound impact that inventions can have on shaping a brighter future for all.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…